BIOVENTUS_LOGO.png
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
08 août 2023 07h30 HE | Bioventus, Inc.
DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
BIOVENTUS_LOGO.png
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
04 août 2023 08h30 HE | Bioventus, Inc.
DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...
BIOVENTUS_LOGO.png
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
01 août 2023 17h35 HE | Bioventus, Inc.
DURHAM, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
BIOVENTUS_LOGO.png
Bioventus Completes Divestiture of its Wound Business
23 mai 2023 07h30 HE | Bioventus, Inc.
DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has...
BIOVENTUS_LOGO.png
Bioventus Reports First Quarter Financial Results
16 mai 2023 16h15 HE | Bioventus, Inc.
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
BIOVENTUS_LOGO.png
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
15 mai 2023 17h33 HE | Bioventus, Inc.
DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report...
BIOVENTUS_LOGO.png
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
11 mai 2023 07h00 HE | Bioventus, Inc.
DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the Company plans to...
BIOVENTUS_LOGO.png
Bioventus Announces Divestiture of its Wound Business
10 mai 2023 09h00 HE | Bioventus, Inc.
DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has signed a...
BIOVENTUS_LOGO.png
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
03 mai 2023 08h30 HE | Bioventus, Inc.
DURHAM, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
BIOVENTUS_LOGO.png
Bioventus Announces CEO Leadership Change
05 avr. 2023 08h00 HE | Bioventus, Inc.
DURHAM, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that Ken M. Reali has...